Miniaturization and characterization of patient derived hepatocellular carcinoma tumor organoid cultures for cancer drug discovery applications
Patient derived tumor organoid (PDTO) models retain the structural, morphological, genetic, and clonal heterogeneity of the original tumors. The ability to efficiently generate, expand, and biobank PDTOs has the potential to make the clinical diversity of cancer accessible for personalized medicine...
Saved in:
Main Authors: | David A. Close, Paul A. Johnston |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | SLAS Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2472555224000637 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human epicardial organoids from pluripotent stem cells resemble fetal stage with potential cardiomyocyte- transdifferentiation
by: Fanwen Wang, et al.
Published: (2025-01-01) -
Cholangiocyte organoids for disease, cancer, and regenerative medicine
by: Munemasa Nagao, et al.
Published: (2025-03-01) -
Organoid development and applications in gynecological cancers: the new stage of tumor treatment
by: Yang Li, et al.
Published: (2025-01-01) -
Intestinal organoids: The path towards clinical application
by: Hady Yuki Sugihara, et al.
Published: (2025-03-01) -
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method
by: Qiu-Shi Feng, et al.
Published: (2025-01-01)